Cargando…

Toxin Induced Parkinsonism and Hospitalization Related Adverse Outcome Mitigation for Parkinson’s Disease: A Comprehensive Review

Patients with Parkinson’s disease admitted to the hospital have unique presentations. This unique subset of patients requires a multidisciplinary approach with a knowledge-based care team that can demonstrate awareness of complications specific to Parkinson’s disease to reduce critical care admissio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalton, Kenneth R., Kidd, Charles J., Hack, Nawaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918159/ https://www.ncbi.nlm.nih.gov/pubmed/36769726 http://dx.doi.org/10.3390/jcm12031074

Ejemplares similares

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Chloramphenicol Mitigates Oxidative Stress by Inhibiting Translation of Mitochondrial Complex I in Dopaminergic Neurons of Toxin-Induced Parkinson's Disease Model
por: Han, Jeongsu, et al.
Publicado: (2019)

Neuroimaging Techniques in Differentiating Parkinson’s Disease from Drug-Induced Parkinsonism: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat
por: Anselmi, L., et al.
Publicado: (2018)

Failure of Diphtheria Toxin Model to Induce Parkinson-Like Behavior in Mice
por: Valek, Lucie, et al.
Publicado: (2021)

Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease
por: Grimmig, Bethany, et al.
Publicado: (2016)

Weight Loss and Impact on Quality of Life in Parkinson’s Disease
por: Akbar, Umer, et al.
Publicado: (2015)

Systems biology analysis of the proteomic alterations induced by MPP(+), a Parkinson's disease-related mitochondrial toxin
por: Monti, Chiara, et al.
Publicado: (2015)

Substance Use Disorders in Patients With Parkinson’s Disease and Adverse Hospitalization Outcomes: A National Inpatient Study
por: Kaur, Jaskaranpreet, et al.
Publicado: (2021)

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease
por: Crispo, James A. G., et al.
Publicado: (2016)

Predictive language comprehension in Parkinson’s disease
por: Aveni, Katharine, et al.
Publicado: (2023)

Pain in monogenic Parkinson’s disease: a comprehensive review
por: Alizadeh, Parisa, et al.
Publicado: (2023)

Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson's Disease
por: Litteljohn, Darcy, et al.
Publicado: (2010)

Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology
por: Pan-Montojo, Francisco, et al.
Publicado: (2014)

Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson's Disease Model
por: Kumar, Hemant, et al.
Publicado: (2013)

Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2016)

Fragility Fractures and Parkinsonism: Relationship of Fractures with Demography, Severity and Predictors of Adverse Outcomes
por: Aithal, Shridhar, et al.
Publicado: (2017)

Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease—A Systematic Review
por: Jabbari, Bahman, et al.
Publicado: (2023)

Parkinson's disease in the elderly and the comprehensive geriatric assessment
por: Lauretani, Fulvio
Publicado: (2013)

Comprehensive Perspectives on Experimental Models for Parkinson’s Disease
por: Ke, Minjing, et al.
Publicado: (2021)

The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
por: Diez-Fairen, Monica, et al.
Publicado: (2021)

Neuropsychiatric Symptoms and Caregiver Burden in Parkinson's Disease: Mitigating the Lack of Awareness!
por: Nene, Devavrat, et al.
Publicado: (2020)

Parkinsonism: A Rare Adverse Effect of Valproic Acid
por: Muralidharan, Abilash, et al.
Publicado: (2020)

Botulinum Toxin A Ameliorates Neuroinflammation in the MPTP and 6-OHDA-Induced Parkinson’s Disease Models
por: Ham, Hyeon Joo, et al.
Publicado: (2022)

Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson’s Disease
por: Du, Yijuan, et al.
Publicado: (2019)

Risk of Hospitalization and Death for COVID‐19 in People with Parkinson's Disease or Parkinsonism
por: Vignatelli, Luca, et al.
Publicado: (2020)

Parkinson-related neuropathy
por: Finsterer, Josef, et al.
Publicado: (2021)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Occurrence of Dysphagia Following Botulinum Toxin Injection in Parkinsonism-related Cervical Dystonia: A Retrospective Study
por: Patterson, Addie, et al.
Publicado: (2016)

Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson’s Disease: A Systematic Review
por: Ruiz-Roca, Juan Antonio, et al.
Publicado: (2019)

Outcome of Hospitalized Parkinson's Disease Patients with and without COVID‐19
por: Parihar, Raminder, et al.
Publicado: (2021)

Patients' Perspective of Comprehensive Parkinson Care in Rural Victoria
por: Iansek, Robert, et al.
Publicado: (2020)

First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes
por: Green, Samantha, et al.
Publicado: (2021)

miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
por: Oliveira, Sara R., et al.
Publicado: (2021)

Mitigating Gait Decline in a Woman With Parkinson’s Disease: A Case Report
por: Chu, Eric Chun-Pu, et al.
Publicado: (2022)

In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
por: Gonzalez-Sepulveda, Marta, et al.
Publicado: (2023)

Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features
por: Kwakye, Gunnar F., et al.
Publicado: (2015)

Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea
por: Han, Sola, et al.
Publicado: (2019)

Drug-Induced Parkinsonism
por: Shin, Hae-Won, et al.
Publicado: (2012)

Are Verbal Fluency and Nonliteral Language Comprehension Deficits Related to Depressive Symptoms in Parkinson's Disease?
por: Tremblay, Christina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_km55rckievvesdv77d4ae34ap7